Swiss company to seek approval for an experimental heart failure treatment sooner than expected, bolstering the prospects of tits cardiovascular franchise.
from WSJ.com: US Business http://ift.tt/1jPgYxU
via IFTTT
from WSJ.com: US Business http://ift.tt/1jPgYxU
via IFTTT
No comments:
Post a Comment